In today’s evolving market, patient support programs (PSPs) are expected to deliver consistent access, affordability and adherence support while remaining flexible enough to adapt to ever-changing payer policy and market dynamics.
This resource brings together insights from life sciences organizations, pharmaceutical consultants and PSP providers to examine how programs are evolving — and what it takes to build solutions that are resilient, scalable and prepared for the needs of tomorrow.
This resource explores:
- The role of digital hubs and direct-to-patient (DTP) models — and how to determine when each approach is most effective.
- Strategies for addressing payer utilization management, including specialty carveouts, accumulators and maximizers.
- Approaches to attracting, enabling and retaining patient support teams amid changing program demands.
- Considerations for supporting access and affordability as Inflation Reduction Act (IRA) policies continue to roll out.
- Methods for improving data accuracy, scalability and reliability to support enhanced program insights.
Download the white paper to explore how life sciences organizations are rethinking patient support in 2026.